SeqLL Installs true Single Molecule Sequencing (tSMS®) Instrument to Support Oncology Research by Dr. David Ting, MD at the Harvard-MGH Cancer Center
November 03, 2017 07:45 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC announced today that it has installed a true Single Molecule Sequencing (tSMS) Instrument at the Harvard-MGH Cancer Center to support oncology research conducted by Dr. David Ting, MD. Dr. Ting is Assistant Professor of Medicine at Harvard Medical School and a medical oncologist... Read more